BioSpace News Archive

CStone Pharmaceuticals (“CStone”, HKEX: 2616), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, today announced that a registrational clinical trial (GEMSTONE-301 study) of the anti-PD-L1 monoclonal antibody sugemalimab in patients with stage III NSCLC

Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) voted 10 yes and 7 no on the question,

Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik) following the announcement of its decision to exercise the call option in February, 2021

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that effective May 27, 2021, it has granted an aggregate of 2,409,717 stock options

BioMarin Pharmaceutical Inc. announced that management will participate in two upcoming virtual conferences.

Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2021 financial results on Monday, May 31 st , 2021 before markets open. A conference call to discuss the financial results will be held on Monday, May 31 st , 2021

Selexis SA, a JSR Life Sciences company, announced that Great Place to Work® has designated the Company among the “Best Workplaces™ Switzerland” in 2021.

DexCom, Inc. announced that management will present an update on Dexcom at the following upcoming investor conference